Tag: diabetes care devices market report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Diabetes Treatment Devices Market Value Growth And Long-Term Outlook

The diabetes treatment devices market size has shown significant growth in recent years. It is anticipated to increase from $12.34 billion in 2025 to $13.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. Historically, this growth can be attributed to the reliance on traditional blood glucose meters, a limited understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising occurrence of diabetes, and the widespread use of standard lancets and testing strips.

The diabetes treatment devices market is set to observe significant expansion over the next few years. It is predicted to attain a value of $16.53 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.0%. This anticipated growth throughout the forecast period stems from factors such as the creation of smart insulin pens and pumps, the increasing adoption of real-time continuous glucose monitoring, the merging of technology with smartphones and wearable devices, the growth of remote patient monitoring initiatives, and the enlargement of diabetes clinics alongside online distribution channels. Prominent trends expected in this period include the escalating uptake of continuous glucose monitoring devices, a rising preference for intelligent insulin delivery systems, an increase in homecare and remote patient observation, the wider availability of wearable and portable glucometers, and an enhanced demand for safety-improved lancets and testing strips.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=74774479&type=smp&name=Diabetes%20Treatment%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Diabetes Treatment Devices Market Demand Drivers: What’s Powering Industry Growth?

The rising prevalence of obesity is projected to stimulate the expansion of the diabetes treatment devices market in the future. Obesity rate defines the proportion of individuals categorized as obese based on their body mass index (BMI). The growing obesity levels are primarily caused by unhealthy eating patterns rich in calories, sugars, and fats, leading to excessive weight gain when not balanced by physical activity. Diabetes treatment devices assist in reducing obesity rates by fostering improved blood sugar control, which in turn supports healthier lifestyle choices and weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, adult obesity rates reached 35% or more in 23 US states in 2023, an increase from 22 states in 2022, indicating a worsening obesity situation. Therefore, increasing obesity rates are propelling the growth of the diabetes treatment devices market.

Diabetes Treatment Devices Market Segment Outlook: Which Categories Are Growing Fastest?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

Diabetes Treatment Devices Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading firms within the diabetes treatment devices market are prioritizing the integration of sophisticated automation technologies, including automated insulin delivery algorithms, to boost the accuracy of treatment and maintain consistent glycemic control. Such algorithms utilize live glucose readings from continuous glucose monitoring sensors to automatically modify basal insulin dosages, thereby assisting in keeping glucose levels within the desired range with very little manual input. A notable example is Medtronic plc, a medical technology firm from the US, which secured FDA approval in April 2023 for its MiniMed 780G System. This automated insulin delivery technology aims to aid those with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system incorporates SmartGuard technology for insulin adjustments that respond to real-time glucose changes, offers Bluetooth connectivity for mobile observation, and includes built-in continuous glucose monitoring support. The MiniMed 780G System contributes to enhanced treatment accuracy, greater glucose stability, and improved daily diabetes management results.

Diabetes Treatment Devices Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

View The Full Diabetes Treatment Devices Market Report:

https://thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Diabetes Treatment Devices Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Diabetes Treatment Devices Market In 2026 And How Much Will It Reach By 2030?

The diabetes treatment devices market has demonstrated strong growth in recent years. This market is expected to expand from $12.34 billion in 2025 to $13.11 billion in 2026, at a compound annual growth rate (CAGR) of 6.2%. The historical increase can be attributed to factors such as reliance on traditional blood glucose meters, limited awareness of self-monitoring devices, expanding hospital and diagnostic center infrastructure, the increasing prevalence of diabetes, and the adoption of standard lancets and testing strips.

The diabetes treatment devices market is projected to experience substantial growth in the upcoming years. This market is anticipated to reach $16.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. The forecasted growth is primarily driven by advancements such as smart insulin pens and pumps, the growing embrace of real-time continuous glucose monitoring, seamless integration with smartphones and wearables, the proliferation of remote patient monitoring initiatives, and the expansion of specialized diabetes clinics and online retail channels. Key trends expected during this period involve the increasing uptake of continuous glucose monitoring devices, a rising preference for intelligent insulin delivery systems, an expansion of homecare and remote patient monitoring solutions, the broadening use of wearable and handheld glucometers, and an elevated demand for improved safety lancets and testing strips.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Primary Factors Are Fueling The Expansion Of The Diabetes Treatment Devices Market?

The rising prevalence of obesity is anticipated to boost the expansion of the diabetes treatment devices market going forward. The obesity rate indicates the proportion of individuals categorized as obese based on their body mass index (BMI). A major contributor to these increasing rates is unhealthy eating patterns, rich in calories, sugars, and fats, which result in significant weight gain when not combined with physical activity. Diabetes treatment devices contribute to lowering obesity rates by encouraging improved blood sugar regulation, thereby fostering healthier lifestyle choices and weight control. For example, in September 2024, data from the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, showed that in 2023, adult obesity rates were 35% or higher in 23 US states, an increase from 22 states in 2022, signaling an escalating obesity problem. Consequently, the growing obesity rates are a key factor propelling the development of the diabetes treatment devices market.

What Are The Major Segment Categories Within The Diabetes Treatment Devices Market?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Trends Are Influencing The Diabetes Treatment Devices Market?

Leading companies operating within the diabetes treatment devices market are increasingly focusing on incorporating advanced automation technologies, such as automated insulin delivery algorithms, to enhance treatment precision and achieve continuous glycemic control. These algorithms leverage real-time glucose data from continuous glucose monitoring sensors to automatically adjust basal insulin dosing, thereby assisting in maintaining glucose levels within the target range with minimal manual intervention. For example, in April 2023, Medtronic plc, a US-based medical technology company, obtained FDA approval for the MiniMed 780G System. This automated insulin delivery technology is specifically designed to support individuals with type 1 diabetes by automatically correcting highs and adjusting insulin delivery every five minutes. The system features SmartGuard technology for real-time, glucose-responsive insulin adjustments, includes Bluetooth connectivity for mobile monitoring, and offers integrated continuous glucose monitoring support. The MiniMed 780G System improves treatment accuracy, enhances glucose stability, and optimizes day-to-day diabetes management outcomes.

Who Are The Leading Firms Participating In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

Access The Complete Diabetes Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

What Is The Largest Regional Market In The Diabetes Treatment Devices Market?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Diabetes Treatment Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Continuous Glucose Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Diabetes Treatment Devices Market Projected To Reach By 2030?

The market for diabetes treatment devices has experienced substantial growth in recent years. This market is projected to expand from $12.34 billion in 2025 to $13.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.2%. Historically, this expansion has been driven by factors such as the dependence on conventional blood glucose meters, a restricted understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising incidence of diabetes, and the widespread use of standard lancets and testing strips.

The market for diabetes treatment devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach $16.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. The anticipated growth during this period stems from several factors, including the advancement of smart insulin pens and pumps, the growing uptake of real-time continuous glucose monitoring, their integration with smartphones and wearable technologies, the proliferation of remote patient monitoring initiatives, and the expansion of diabetes clinics along with online distribution avenues. Key trends foreseen for the forecast horizon encompass the escalating adoption of continuous glucose monitoring devices, a growing inclination towards smart insulin delivery systems, an increase in homecare and remote patient monitoring, the broader availability of wearable and handheld glucometers, and an elevated demand for safety-improved lancets and testing strips.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

Which Primary Drivers Are Impacting The Diabetes Treatment Devices Market Growth?

The future growth of the diabetes treatment devices market is expected to be propelled by increasing obesity rates. The obesity rate indicates the percentage of individuals classified as obese based on their body mass index (BMI). These rising obesity rates are primarily a result of unhealthy diets, rich in calories, sugars, and fats, which cause excessive weight gain when not balanced with physical activity. Diabetes treatment devices contribute to reducing obesity rates by fostering better blood sugar control, thereby supporting healthier lifestyle habits and weight management. For instance, in September 2024, data from the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, revealed that in 2023, adult obesity rates reached 35% or higher in 23 US states, an increase from 22 states in 2022, highlighting a deteriorating obesity trend. Therefore, the rise in obesity rates is a key driver for the expansion of the diabetes treatment devices market.

How Are Different Segments Classified In The Diabetes Treatment Devices Market Segment Analysis?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

Which Trends Are Shaping Growth In The Diabetes Treatment Devices Market?

Leading firms within the diabetes treatment devices market are prioritizing the integration of sophisticated automation technologies, including automated insulin delivery algorithms, to improve the accuracy of treatment and ensure consistent glycemic management. Such algorithms leverage real-time glucose information from continuous glucose monitoring sensors to autonomously modify basal insulin doses, thereby assisting in keeping glucose levels within the desired range with very little human involvement. As an example, in April 2023, Medtronic plc, a medical technology company based in the US, secured FDA approval for its MiniMed 780G System, which is an automated insulin delivery solution intended to assist people with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. This system incorporates SmartGuard technology for insulin adjustments that respond to glucose levels in real-time, offers Bluetooth connectivity for convenient mobile monitoring, and provides integrated continuous glucose monitoring capabilities. The MiniMed 780G System enhances the precision of treatment, promotes glucose stability, and leads to better daily diabetes management results.

Who Are The Companies Driving Activity In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

Get The Full Diabetes Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Has The Greatest Market Share In The Diabetes Treatment Devices Market?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diabetes Treatment Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Continuous Glucose Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Diabetes Treatment Devices Market Across 2026–2030?

The diabetes treatment devices market size has shown substantial growth in recent years. This market is forecasted to increase from $12.34 billion in 2025 to $13.11 billion in 2026, advancing at a compound annual growth rate (CAGR) of 6.2%. The expansion observed in prior periods can be attributed to factors like the reliance on traditional blood glucose meters, limited understanding of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, a rising incidence of diabetes, and the widespread adoption of standard lancets and testing strips.

The diabetes treatment devices market is projected to undergo significant growth in the upcoming years. It is forecast to achieve a valuation of $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This anticipated expansion during the forecast period is primarily driven by the advancement of smart insulin pens and pumps, the increasing acceptance of real-time continuous glucose monitoring, its integration with smartphones and wearable technologies, the rise in remote patient monitoring programs, and the growth of diabetes clinics along with online distribution channels. Prominent trends expected in this period include the wider adoption of continuous glucose monitoring devices, a growing preference for intelligent insulin delivery systems, an increase in homecare and remote patient monitoring services, the expansion of wearable and handheld glucometers, and an elevated demand for safety-enhanced lancets and testing strips.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

Which Market Drivers Are Supporting The Expansion Of The Diabetes Treatment Devices Market?

The future growth of the diabetes treatment devices market is expected to be propelled by the escalating obesity rates. The obesity rate indicates the proportion of individuals categorized as obese based on their body mass index (BMI). These rising obesity rates primarily result from unhealthy diets high in calories, sugars, and fats, leading to excessive weight gain when not balanced with physical activity. Diabetes treatment devices assist in reducing obesity rates through promoting superior blood sugar control, which in turn supports healthier lifestyle habits and effective weight management. For instance, in September 2024, according to the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, adult obesity rates in 2023 reached 35% or higher in 23 US states, an increase from 22 states in 2022, indicating a worsening obesity trend. Thus, increasing obesity rates are a key driver for the growth of the diabetes treatment devices market.

What Segmentation Levels Are Considered In The Diabetes Treatment Devices Market?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Trends Are Projected To Affect The Diabetes Treatment Devices Market?

Leading companies operating in the diabetes treatment devices market are concentrating on integrating sophisticated automation technologies, such as automated insulin delivery algorithms, to enhance treatment precision and facilitate continuous glycemic control. These algorithms utilize real-time glucose data from continuous glucose monitoring sensors to automatically adjust basal insulin dosing, thereby helping to maintain glucose levels within the target range with minimal manual intervention. For instance, in April 2023, Medtronic plc, a US-based medical technology company, secured FDA approval for the MiniMed 780G System, an automated insulin delivery technology designed to support individuals with type 1 diabetes by automatically correcting highs and adjusting insulin delivery every five minutes. The system incorporates SmartGuard technology for real-time glucose-responsive insulin adjustments, offers Bluetooth connectivity for mobile monitoring, and provides integrated continuous glucose monitoring support. The MiniMed 780G System improves treatment accuracy, enhances glucose stability, and optimizes day-to-day diabetes management outcomes.

Which Leading Firms Are Contributing To The Growth Of The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

Read the full diabetes treatment devices market report here:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

How Is The Diabetes Treatment Devices Market Distributed Across Key Geographic Regions?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Diabetes Treatment Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Continuous Glucose Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How is the Diabetes Treatment Devices Market size predicted to change over the forecast window of 2026–2035?

The market for diabetes treatment devices has shown substantial growth in recent years. It is anticipated to expand from $12.34 billion in 2025 to $13.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This historical growth was influenced by factors such as the prevalence of traditional blood glucose meters, restricted awareness of self-monitoring devices, the expansion of hospital and diagnostic center infrastructure, the rising prevalence of diabetes, and the adoption of standard lancets and testing strips.

The diabetes treatment devices market is projected to experience robust expansion over the next few years. It is expected to reach $16.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This projected growth can be attributed to the development of smart insulin pens and pumps, increasing adoption of real-time continuous glucose monitoring, integration with smartphones and wearable devices, expanding remote patient monitoring programs, and the growth of diabetes clinics and online distribution channels. Prominent trends anticipated during this period include the growing uptake of continuous glucose monitoring devices, a rising preference for smart insulin delivery systems, an increase in homecare and remote patient monitoring, the expansion of wearable and handheld glucometers, and a heightened demand for safety-enhanced lancets and testing strips.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

Which Drivers Are Contributing To The Expansion Of The Diabetes Treatment Devices Market?

The future growth of the diabetes treatment devices market is anticipated to be propelled by increasing obesity rates. An obesity rate refers to the proportion of individuals classified as obese based on their body mass index (BMI). These rising obesity rates are primarily attributed to unhealthy diets high in calories, sugars, and fats, which lead to excessive weight gain when not balanced with physical activity. Diabetes treatment devices contribute to reducing obesity rates by fostering better blood sugar control, thereby supporting healthier lifestyle habits and weight management. For instance, in September 2024, the US Centers for Disease Control and Prevention (CDC), an US-based national public-health agency, reported that in 2023, adult obesity rates reached 35% or higher in 23 US states, an increase from 22 states in 2022, signaling a worsening obesity trend. Thus, increasing obesity rates are driving the growth of the diabetes treatment devices market.

What Segment Categories Are Covered In The Diabetes Treatment Devices Market?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Trends Are Reshaping The Dynamics Of The Diabetes Treatment Devices Market?

Leading companies in the diabetes treatment devices market are emphasizing the integration of sophisticated automation technologies, such as automated insulin delivery algorithms, to improve treatment precision and achieve continuous glycemic control. These algorithms utilize real-time glucose data from continuous glucose monitoring sensors to autonomously adjust basal insulin dosing, aiding in the maintenance of glucose levels within the target range with minimal manual oversight. For example, in April 2023, Medtronic plc, a US-based medical technology company, obtained FDA approval for the MiniMed 780G System, an automated insulin delivery technology crafted to assist individuals with type 1 diabetes by automatically rectifying high glucose levels and adjusting insulin delivery every five minutes. The system is equipped with SmartGuard technology for insulin adjustments that respond to real-time glucose, features bluetooth connectivity for mobile monitoring, and provides integrated continuous glucose monitoring support. The MiniMed 780G System enhances treatment accuracy, glucose stability, and daily diabetes management outcomes.

Which Key Players Are Driving Competition In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson And Company, Hoffmann-La Roche Ltd, Insulet Corporation, DexCom Inc, Tandem Diabetes Care Inc, Lifescan Inc, Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc, Bigfoot Biomedical Inc, Medtrum Technologies Inc, Diabeloop SA, Roche Diabetes Care GmbH, Insulet Inc, Omnipod Inc, Tandem Inc, Abbott Diabetes Care

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

How Does The Diabetes Treatment Devices Market Perform Across Major Global Regions?

North America was the largest region in the diabetes treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diabetes Treatment Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Diabetes Treatment Devices Market Expected To Expand Between 2025 And 2029?

The diabetes treatment devices market size has experienced strong growth in recent years. It is forecast to grow from $11.61 billion in 2024 to $12.34 billion in 2025, at a compound annual growth rate (CAGR) of 6.3%. This historical growth can be attributed to the increasing prevalence of diabetes, heightened awareness about diabetes management, the growing adoption of insulin delivery devices, rising healthcare expenditure in developing countries, and the increasing availability of advanced glucose monitoring systems.

The diabetes treatment devices market size is projected to experience substantial expansion in the coming years, with expectations to reach $15.61 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. This anticipated growth over the forecast period is attributable to several key factors, including the escalating demand for wearable and non-invasive monitoring devices, a rising focus on personalized diabetes care, the increasing adoption of digital health platforms and applications, a growing need for remote diabetes management solutions, and greater governmental initiatives aimed at promoting diabetes control programs. Concurrently, major trends expected during this period involve significant advancements in continuous glucose monitoring technology, the development of sophisticated insulin delivery systems integrated with artificial intelligence, the creation of smart wearable diabetes devices, innovation in non-invasive blood sugar monitoring methods, and the integration of voice assistants into device operations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Diabetes Treatment Devices Industry?

The future expansion of the diabetes treatment devices market is anticipated due to escalating obesity rates. An individual’s body mass index (BMI) is used to determine the obesity rate, which indicates the proportion of people categorized as obese. A primary cause of these escalating obesity rates is diets rich in calories, sugars, and fats, resulting in significant weight gain without adequate physical exercise. By facilitating improved blood sugar management, diabetes treatment devices contribute to lowering obesity rates, thereby encouraging healthier lifestyles and effective weight control. For example, data from the Centers for Disease Control and Prevention, a US-based government agency, revealed in September 2023 that 22 U.S. states recorded an adult obesity rate of 35% or higher in 2022, an increase from 19 states in 2021. Consequently, the expanding obesity rates are fueling the development of the diabetes treatment devices market.

What Are The Major Segment Categories Driving The Diabetes Treatment Devices Market Growth?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

What Long-Term Trends Will Shape The Future Growth Of The Diabetes Treatment Devices Industry?

Major companies in the diabetes treatment devices market are concentrating on developing innovative solutions, such as hybrid closed-loop insulin pump systems, to enhance glycemic control and lessen the burden of diabetes management for patients. A hybrid closed-loop insulin pump system is an advanced diabetes device that automatically adjusts insulin delivery based on continuous glucose monitor (CGM) readings, while requiring users to manually input mealtime insulin doses. For instance, in March 2022, Medtronic PLC, an Ireland-based medical device company, introduced the MiniMed 780G system, featuring SmartGuard technology for managing type 1 diabetes in individuals aged 7 to 80 years. This sophisticated system automatically regulates basal insulin and delivers correction boluses every five minutes to help maintain glucose levels within a personalized target range, even compensating for missed meal boluses or incorrect carbohydrate estimates. It also includes Meal Detection technology, a continuous glucose monitor that eliminates the need for fingersticks, and an infusion set designed for up to seven days of wear, all of which are accessible and manageable through a connected mobile app.

Who Are The Core Companies Influencing The Diabetes Treatment Devices Market Landscape?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Diabetes Treatment Devices Market?

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Diabetes Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2025, By The Business Research Company

Diabetes Care Devices Market 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Pet Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Diabetes Treatment Devices Market?

The market size of diabetes treatment devices has witnessed substantial growth of late. It is projected to rise from $11.61 billion in 2024 to $12.34 billion in 2025, charting a compound annual growth rate (CAGR) of 6.3%. This growth experienced in the past can be credited to factors such as the rise in diabetes cases, greater awareness regarding diabetes control, heightened usage of insulin delivery devices, increased healthcare spending in developing nations, and the extensive availability of advanced glucose monitoring systems.

The market size for diabetes treatment devices is projected to experience significant growth in the coming years. By 2029, it is predicted to expand to $15.61 billion with a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is anticipated to be driven by the increasing demand for wearable and non-invasive monitoring devices, the heightened focus on individualized diabetes care, and a surge in the adoption of digital health platforms and applications. Additionally, the rising demand for off-site diabetes management solutions and an increase in government initiatives that encourage diabetes control programs are instrumental in this growth. Dominant trends expected in the forecast period are improvements in continuous glucose monitoring technology, sophisticated insulin delivery systems implemented with artificial intelligence, the evolution of advanced wearable diabetes devices, progress in non-invasive blood sugar monitoring, and the inclusion of voice assistants in device functionality.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Diabetes Treatment Devices Market?

The rise in obesity rates is projected to spur the expansion of the market for diabetes treatment devices in the coming years. Obesity rate is defined as the proportion of people deemed obese based on their body mass index (BMI). Unhealthy high-calorie, high-sugar, and high-fat diets are the principal contributors to rising obesity rates, leading to excessive weight accumulation when not complemented with physical exercise. Diabetes treatment devices contribute to decreasing obesity rates by improving blood sugar regulation, fostering healthier lifestyle habits and weight management. For example, as per the Centers for Disease Control and Prevention, a government entity based in the U.S., 22 American states reported an adult obesity rate of 35% or more in 2022, an increase from 19 states in 2021. Thus, climbing obesity rates are a major driver for the escalation of the diabetes treatment devices market.

What Are The Key Segment Trends Observed In The Diabetes Treatment Devices Market?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

Which Disruptive Trends Are Driving Change Across The Diabetes Treatment Devices Market?

In attempts to streamline diabetes management and enhance glycemic control, major corporations in the diabetes treatment devices market are focusing on the innovation of solutions like hybrid closed-loop insulin pump systems. These advanced systems autonomously regulate insulin distribution based on the continuous glucose monitor (CGM) readings, although they still require manual entries for food-related insulin doses. For example, in March 2022, Ireland’s Medtronic PLC released the MiniMed 780G system, designed with SmartGuard technology to manage type 1 diabetes for people aged between 7 and 80. This cutting-edge system fine-tunes basal insulin and administers correctional boluses at five-minute intervals to ensure glucose levels stay within a personalized target range. The system accommodates for missed meal boluses or inaccurate carbohydrate estimates, and it is fitted with a Meal Detection technology and a self-sustaining glucose monitor that eliminates the need for finger pricking. It even has an infusion set built for up to a week’s worth of use, all manageable via an associated mobile application.

Who Are The Leading Companies Driving The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Is Forecasted To Lead The Diabetes Treatment Devices Market In The Coming Years?

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

Browse Through More Reports Similar to the Global Diabetes Treatment Devices Market 2025, By The Business Research Company

Continuous Glucose Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Diabetes Pen Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-pen-global-market-report

Antidiabetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Diabetes Treatment Devices Market From 2025 to 2029?

In recent times, there has been a significant expansion in the market for diabetes treatment devices. Its size is projected to increase from $11.61 billion in 2024 to $12.34 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.3%. The growth observed in the historical period is credited to the heightened prevalence of diabetes, enhanced understanding of diabetes management, increased use of insulin delivery devices, higher healthcare spending in developing nations, and an upsurge in the availability of sophisticated glucose monitoring systems.

In the forthcoming years, the diabetes treatment devices market is likely to witness significant expansion. The market is projected to reach a value of $15.61 billion in 2029, progressing at a compound annual growth rate (CAGR) of 6.1%. This growth during the predicted timeline could be driven by factors such as an increased demand for wearable and non-invasive monitoring gadgets, a rising emphasis on individualized diabetes care, broader adoption of digital health platforms and applications, augmented demand for remote diabetes management services, and growing government initiatives supporting diabetes control programs. The trending factors anticipated during this timeframe include advancements in continuous glucose monitoring technology, refined insulin delivery systems with artificial intelligence incorporation, the creation of smart wearable diabetes gadgets, innovation in non-invasive blood sugar monitoring, and the implementation of voice assistants in device functionality.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25750&type=smp

What Elements Are Contributing To Growth In The Diabetes Treatment Devices Market?

The rise in obesity rates is anticipated to fuel the expansion of the market for diabetes treatment devices moving ahead. The obesity rate is a measure of the proportion of people deemed obese according to their body mass index (BMI). Unhealthy diets rich in calories, sugars, and fats, which can result in significant weight gain if not counteracted by physical exercise, are largely contributing to the rise in obesity rates. Devices used for diabetes treatment aid in lowering obesity rates by fostering improved blood sugar regulation, thus promoting healthier lifestyle choices and weight management. For instance, as per the Centers for Disease Control and Prevention, a government agency based in the US, in 2022, 22 American states noted an adult obesity rate of 35% or more, an increase from 19 states in 2021. Therefore, this surge in obesity rates is stimulating the expansion of the market for diabetes treatment devices.

Which Segments Are Detailed In The Global Diabetes Treatment Devices Market Report?

The diabetes treatment devices market covered in this report is segmented –

1) By Device Type: Blood Glucose Monitoring Devices, Self-Monitoring Devices, Blood Glucose Meters, Testing Strips, Lancets, Continuous Glucose Monitoring Devices, Sensors, Transmitters, Receiver, Other Device Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics Or Centers, Institutional Sales, Online Pharmacies, Other Distribution Channels

3) By End-User: Hospitals, Homecare, Diagnostic Centers, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Blood Glucose Monitoring Devices: Invasive Blood Glucose Monitoring Devices, Non-Invasive Blood Glucose Monitoring Devices

2) By Self-Monitoring Devices: Handheld Glucometers, Wearable Self-Monitoring Devices

3) By Blood Glucose Meters: Standard Glucose Meters, Smart Or Connected Glucose Meters

4) By Testing Strips: Glucose Oxidase Strips, Glucose Dehydrogenase Strips

5) By Lancets: Standard Lancets, Safety Lancets

6) By Continuous Glucose Monitoring Devices: Real-Time Continuous Glucose Monitoring Devices, Intermittently Scanned Continuous Glucose Monitoring Devices

7) By Sensors: Short-Term Sensors, Long-Term Implantable Sensors

8) By Transmitters: Reusable Transmitters, Disposable Transmitters

9) By Receiver: Dedicated Continuous Glucose Monitoring Devices Monitors, Smartphone Or Smartwatch-Connected Receivers

10) By Other Device Types: Insulin Pens, Insulin Pumps, Smart Insulin Patches

Which Emerging Trends And Strategic Shifts Are Shaping The Diabetes Treatment Devices Market?

Leading companies in the diabetes treatment devices market are prioritizing the creation of innovative solutions like hybrid closed-loop insulin pump systems. These systems enhance glycemic control and simplify diabetes management for patients. Hybrid closed-loop insulin pump systems are sophisticated diabetes devices that self-regulate insulin delivery based on continuous glucose monitoring (CGM) data. However, they still need users to manually enter their insulin doses during mealtime. For example, in March 2022, Medtronic PLC, a medical device corporation based in Ireland, introduced the MiniMed 780G system. This system, equipped with SmartGuard technology, is dedicated to managing type 1 diabetes in individuals from 7 to 80 years of age. The advanced system self-adjusts basal insulin and administers correction boluses every five minutes. This helps to sustain glucose levels within a personal target range and corrects for missed meal boluses or discrepancies in carbohydrate computation. The system also comes with Meal Detection technology, a fingerstick-free continuous glucose monitor, and an infusion set meant for up to a week’s use. These features can be accessed and controlled using a dedicated mobile application.

Who Are The Key Contributors To Growth In The Diabetes Treatment Devices Market?

Major companies operating in the diabetes treatment devices market are Johnson And Johnson, Abbott Laboratories, Medtronic plc, Eli Lilly And Company, Novo Nordisk A/S, Becton, Dickinson And Company, Hoffmann-La Roche Ltd., Insulet Corporation, DexCom Inc., Tandem Diabetes Care Inc, Lifescan Inc., Ypsomed Holding AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beta Bionics Inc, Senseonics Holdings Inc., Bigfoot Biomedical Inc., Medtrum Technologies Inc., Diabeloop SA, Roche Diabetes Care GmbH

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/diabetes-treatment-devices-global-market-report

Which Region Is Projected To Lead The Diabetes Treatment Devices Market By 2025?

North America was the largest region in the diabetes treatment devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25750&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model